Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S331000, C544S364000, C546S268100
Reexamination Certificate
active
07977348
ABSTRACT:
Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described. The structure diagram below shows the chemical structure of imatinib mesylate.
REFERENCES:
patent: 5521184 (1996-05-01), Zimmermann
patent: 6894051 (2005-05-01), Zimmermann et al.
patent: 7081532 (2006-07-01), Buerger et al.
patent: 7550591 (2009-06-01), Xing et al.
patent: 2004/0248918 (2004-12-01), Kim et al.
patent: 2006/0030568 (2006-02-01), Zimmermann et al.
patent: 2006/0149061 (2006-07-01), Anli et al.
patent: 2006/0223816 (2006-10-01), Adin et al.
patent: 2006/0223817 (2006-10-01), Adin et al.
patent: WO-99/03854 (1999-01-01), None
patent: WO-03/066613 (2003-08-01), None
patent: WO-2004/074502 (2004-09-01), None
patent: WO-2004/106326 (2004-12-01), None
patent: WO-2004/108699 (2004-12-01), None
patent: WO-2005/077933 (2005-08-01), None
patent: WO-2005/095379 (2005-10-01), None
patent: WO-2006/024863 (2006-03-01), None
patent: WO-2006/048890 (2006-05-01), None
patent: WO-2006/054314 (2006-05-01), None
patent: WO-2006/071130 (2006-07-01), None
patent: WO-2007/023182 (2007-03-01), None
patent: WO-2009/080366 (2009-07-01), None
ICH Harmonised Tripartite Guideline, “Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients”, Q7A, Current Step 4 Version, Nov. 10, 2000.
Strobel, Howard A., et al., “Chemical Instrumentation: A Systematic Approach”, 3rdedition, Wiley & Sons, New York, 1989, p. 953.
Aronhime Judith
Chudík Miloslav
Faustmann Ji{hacek over (r)}í
Gavenda Ale{hacek over (s)}
Jegorov Alexandr
Kenyon & Kenyon LLP
Sicor Inc.
Willis Douglas M
Wilson James O
LandOfFree
Polymorphic forms of imatinib mesylate and processes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphic forms of imatinib mesylate and processes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic forms of imatinib mesylate and processes for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2627614